jeudi 24 mars 2016

Onco Actu du 24 mars 2016

1. Biologie

CRISPR And Beyond: UCSD-Doudna Work Attracts Paul Allen's Millions [Xconomy]

3.1 Tabac

Cigar industry faces the possibility of unprecedented regulation [STAT]

WHO urges India to implement larger health warnings on cigarette packs [Reuters]

5. Traitements

Many Targeted Cancer Therapies Suppress T Cell Immune Responses [Wistar Institute]

Seeking kinder ways to tackle childhood cancer [The Institute of Cancer Research]

5.10 Traitements - Essais

ASCO Tool Found to be an Effective and Easy Way to Manage and Monitor Clinical Trial-Associated Workload [ASCO]

5.2 Pharma

Tarveda Formally Spins Out Placon to Advance Platinum Cancer Drugs [Xconomy]

5.2.1 Pharma - Partenariats

Roche Looks Outside Its Labs to Expand Cancer Drug's Potential [Bloomberg]

5.2.3 Pharma - économie

Roche CEO Schwan beats Novartis chief with $12.3M in 2015 pay, but U.S. companies shell out more [FiercePharma]

5.3 Traitements - FDA, EMA,...

FDA Updates Breakthrough Therapy Program: Meet the Preliminary Breakthrough Therapy Designation Request [FDA Law Blog]

5.5 ASCO

Clifford A. Hudis Named ASCO’s Next Chief Executive Officer [ASCO]

6. Lutte contre les cancers

The Who's Roger Daltrey: Teens with cancer deserve better [STAT]

6.1 Observation

How much does chemo impact fertility? [Fred Hutch]

6.10 Politiques

India defends right to issue drug 'compulsory licenses' [Reuters]

6.11 Patients

One man's desperate quest for a brutal appendix cancer surgery [STAT]

6.6 Publications

On pastrami and the business of PLOS [it is NOT junk]